Q2 2024 Holdings
Filed 2024-08-14 | 79 holdings | $7.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | SH | 04351P101 | $1.4B | 10,108,400 | 18.2% |
| Vaxcyte Inc(PCVX) | SH | 92243G108 | $619.5M | 8,203,754 | 8.2% |
| Janux Therapeutics Inc(JANX) | SH | 47103J105 | $383.9M | 9,165,652 | 5.1% |
| Legend Biotech Corp(LEGN) | SH | 52490G102 | $332.5M | 7,506,934 | 4.4% |
| Rhythm Pharmaceuticals Inc(RYTM) | SH | 76243J105 | $249.8M | 6,084,412 | 3.3% |
| Biogen Inc(BIIB) | SH | 09062X103 | $227.7M | 982,139 | 3.0% |
| Eliem Therapeutics Inc(CLYM) | SH | 28658R106 | $223.4M | 31,419,267 | 3.0% |
| Rxsight Inc(RXST) | SH | 78349D107 | $222.3M | 3,694,825 | 2.9% |
| Avidity Biosciences Inc(RNA) | SH | 05370A108 | $220.6M | 5,400,408 | 2.9% |
| Dyne Therapeutics Inc(DYN) | SH | 26818M108 | $213.5M | 6,049,204 | 2.8% |
| Geron Corp(GERN) | SH | 374163103 | $195.9M | 46,202,425 | 2.6% |
| Pepgen Inc(PEPG) | SH | 713317105 | $170.6M | 10,689,545 | 2.3% |
| Tyra Biosciences Inc(TYRA) | SH | 90240B106 | $166.6M | 10,416,609 | 2.2% |
| Evolent Health Inc(EVH) | SH | 30050B101 | $162.8M | 8,514,862 | 2.2% |
| Edgewise Therapeutics Inc(EWTX) | SH | 28036F105 | $160.5M | 8,909,091 | 2.1% |
| Newamsterdam Pharma Co NV(NAMS) | SH | N62509109 | $154.9M | 8,064,000 | 2.0% |
| Recursion Pharmaceuticals(RXRX) | SH | 75629V104 | $115.4M | 15,384,615 | 1.5% |
| 89Bio Inc(ETNBGBP) | SH | 282559103 | $113.5M | 14,175,398 | 1.5% |
| Verona Pharma PLC(VRNA) | SH | 925050106 | $110.4M | 7,632,646 | 1.5% |
| DAY One Biopharmaceuticals I(DAWN) | SH | 23954D109 | $108.5M | 7,871,721 | 1.4% |
| 4D Molecular Therapeutics in(FDMT) | SH | 35104E100 | $107.0M | 5,098,211 | 1.4% |
| ARS Pharmaceuticals Inc(SPRY) | SH | 82835W108 | $92.4M | 10,860,977 | 1.2% |
| Wave Life Sciences LTD(WVE) | SH | Y95308105 | $90.8M | 18,202,009 | 1.2% |
| Longboard Pharmaceuticals in | SH | 54300N103 | $88.9M | 3,289,119 | 1.2% |
| Arcellx Inc(ACLX) | SH | 03940C100 | $88.5M | 1,604,014 | 1.2% |
| Axsome Therapeutics Inc(AXSM) | SH | 05464T104 | $80.5M | 1,000,000 | 1.1% |
| Apogee Therapeutics Inc(APGE) | SH | 03770N101 | $77.2M | 1,961,863 | 1.0% |
| GH Research PLC(GHRS) | SH | G3855L106 | $77.0M | 6,601,689 | 1.0% |
| Structure Therapeutics Inc(GPCR) | SH | 86366E106 | $74.5M | 1,896,772 | 1.0% |
| Lenz Therapeutics Inc(LENZ) | SH | 52635N103 | $72.3M | 4,178,823 | 1.0% |
| Fulcrum Therapeutics Inc(FULC) | SH | 359616109 | $72.0M | 11,609,704 | 1.0% |
| Nkarta Inc(NKTX) | SH | 65487U108 | $63.9M | 10,805,129 | 0.8% |
| Dianthus Therapeutics Inc(DNTH) | SH | 252828108 | $60.4M | 2,333,000 | 0.8% |
| Mineralys Therapeutics Inc(MLYS) | SH | 603170101 | $56.8M | 4,850,984 | 0.8% |
| Iteos Therapeutics Inc(5E7) | SH | 46565G104 | $52.2M | 3,517,259 | 0.7% |
| Urogen Pharma LTD(URGN) | SH | M96088105 | $51.7M | 3,083,430 | 0.7% |
| Praxis Precision Medicines I(PRAX) | SH | 74006W207 | $51.1M | 1,235,599 | 0.7% |
| Enliven Therapeutics Inc(ELVN) | SH | 29337E102 | $49.6M | 2,122,465 | 0.7% |
| Acrivon Therapeutics Inc(ACRV) | SH | 004890109 | $48.4M | 8,340,508 | 0.6% |
| Astria Therapeutics Inc(CATBUSD) | SH | 04635X102 | $45.9M | 5,043,756 | 0.6% |
| Bicycle Therapeutics PLC(BCYC) | SH | 088786108 | $45.6M | 2,253,000 | 0.6% |
| CG Oncology Inc(CGON) | SH | 156944100 | $44.1M | 1,397,433 | 0.6% |
| Larimar Therapeutics Inc(LRMR) | SH | 517125100 | $43.8M | 6,045,351 | 0.6% |
| Acumen Pharmaceuticals Inc(ABOS) | SH | 00509G209 | $36.1M | 14,932,063 | 0.5% |
| Tourmaline BIO Inc(TRML) | SH | 89157D105 | $32.7M | 2,538,925 | 0.4% |
| Third Harmonic BIO Inc(THRD) | SH | 88427A107 | $26.4M | 2,033,056 | 0.3% |
| Solid Biosciences Inc(SLDB) | SH | 83422E204 | $24.6M | 4,330,446 | 0.3% |
| Taysha Gene Therapies Inc(TSHA) | SH | 877619106 | $24.4M | 10,872,503 | 0.3% |
| Tenaya Therapeutics Inc(TNYA) | SH | 87990A106 | $23.6M | 7,622,347 | 0.3% |
| VOR Biopharma Inc | SH | 929033108 | $22.7M | 22,748,880 | 0.3% |